Clinical Trial Update: Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3, risperidone-controlled multicenter clinical trial of iloperidone for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Iloperidone (iloperidone)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Schizophrenia | Phase 3 | Status: UNKNOWN